- Home
- MDGL vs MTCH Comparison
MDGL vs MTCH Comparison
Compare MDGL & MTCH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MDGL | MTCH |
|---|---|---|
| Founded | 2011 | 1986 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Programming Data Processing |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.1B | 9.1B |
| IPO Year | 2005 | 2004 |
Fundamental Metrics
Financial Performance| Metric | MDGL | MTCH |
|---|---|---|
| Price | $549.60 | $39.16 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 12 | 12 |
| Target Price | ★ $674.45 | $35.17 |
| AVG Volume (30 Days) | 306.0K | ★ 3.7M |
| Earning Date | 05-06-2026 | 05-05-2026 |
| Dividend Yield | N/A | ★ 2.16% |
| EPS Growth | ★ 41.32 | 17.82 |
| EPS | N/A | ★ 0.68 |
| Revenue | $180,133,000.00 | ★ $3,487,197,000.00 |
| Revenue This Year | $58.39 | $2.15 |
| Revenue Next Year | $48.55 | $3.82 |
| P/E Ratio | ★ N/A | $56.41 |
| Revenue Growth | N/A | ★ 0.22 |
| 52 Week Low | $286.75 | $28.81 |
| 52 Week High | $615.00 | $39.79 |
Technical Indicators
Market Signals| Indicator | MDGL | MTCH |
|---|---|---|
| Relative Strength Index (RSI) | 61.89 | 63.40 |
| Support Level | $498.59 | $29.86 |
| Resistance Level | $572.20 | N/A |
| Average True Range (ATR) | 21.95 | 1.28 |
| MACD | 5.25 | 0.28 |
| Stochastic Oscillator | 77.24 | 87.03 |
Price Performance
Historical ComparisonAbout MDGL Madrigal Pharmaceuticals Inc.
Madrigal Pharmaceuticals Inc is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease with high unmet medical need that can lead to cirrhosis, liver failure, liver cancer, need for liver transplantation and premature mortality. Its medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed thyroid hormone receptor beta agonist designed to target key underlying causes of MASH.
About MTCH Match Group Inc.
Match Group Inc is a provider of online dating products. The company's portfolio of brands includes Tinder, Hinge, Match, Meetic, OkCupid, Pairs, Plenty Of Fish, Azar, BLK, and more, each built to increase its user's likelihood of connecting with others. The company has four operating segments: Tinder, Hinge, Evergreen and Emerging, and Match Group Asia. It generates the majority of its revenue from the Tinder segment.